Mingling from 11:30
12:00–15:15 Part I – Norwegian life science industry outlook
Moderator: Tom Pike, Life science industry professional
12:00 –12:10 Opening address
Karita Bekkemellem,CEO, Legemiddelindustrien
12:10–12:50 Rising innovation – things are happening in Norway!
Pitches from startups, incubators and investors
(In English)
Presenting companies:
- Vaccibody, AgnetheFredriksen, CSO
- Nordic Nanovector, Tone Kv?le, CFO
- Phoenix Solutions,
- Per Christian Sontum, CEO
- Oncoinvent, an Allan Alfheim, CEO
- Aleap, Erling Nordb?, CEO
- SarsiaSeed, ?ivind Enger, Partner Inv. Advisor
12:50–14:10 Policies & resources – How to generate investments and growth
International leaders give their views on the implications of the new industry business model
(In English)
Keynote speakers:
- Dieter Ziegler, Dir. Search & Evaluation,Europe, AbbVie
- Jan-OlofJacke, CEO Astra Zeneca AB
- Oliver Rittgen, CEO Bayer Nordic
- Tine Hartmann Nilsen, Invest in Denmark
14:10–14:45 Policies & resources – Plenary discussion
(In English)
Participants:
- Kristin ?rmen Johnsen, Member of Parliament, The Conservative Party of Norway
- Ingvild Kjerkhol, Member of Parliament,The Norwegian Labour Party
- Keynote speakers
14:45–15:15 Refreshments
15:15–18:00 Part II – How can we turn public health data and research into business?
Moderator: Tom Pike, Life science industry professional
15:15 –16:35 Partnerships for growth and better health
The Norwegian Health and Care strategy, HO21, depicts the ambitions for public private partnerships in order to achieve better health, excellent research and business development. Industry, academia and public sector will present best practices and opportunities to fulfill this ambition.
(In Norwegian)
Keynote speakers:
- Camilla Stoltenberg, Chair of HO21-Advisory Board
- Anders M?larstig, Director Human Genetics, Pfizer Global
- Tom Hemming KarlsenProfessor, Faculty of Medicine, UiO
16:35–17:00 Short break
17:00–17:30 Health data and commercial use/exploration
(In Norwegian)
Keynote speakers:
- Roar Olsen, Div.Dir., The Norwegian Directorate of eHealth
- Espen Enerly, Researcher, Cancer Registry of Norway
17:30–18:00 Concluding remarks – Where do we go from here?
Comments from presenters and audience
(In Norwegian)
